marketing approval

FDA

Marketing

FDA proposes yanking approval for AMAG Pharma's Makena

The FDA proposed withdrawing marketing approval for AMAG's Makena just days after the company agreed to a $647 million buyout from Clovis Group.

Kyle Blankenship Oct 6, 2020 11:32am

Mycapssa

Chiasma secures comeback FDA nod for acromegaly pill Mycapssa

Jun 26, 2020 1:30pm

railroad

Drugmakers blaze a path for new therapy launches during COVID-19

Jun 18, 2020 11:00am

thumbs down

FDA experts vote to pull AMAG's premature-birth med Makena

Oct 30, 2019 10:30am

5 Financial Red Flags

FDA review of troubled drug could hobble AMAG in proxy fight

Sep 26, 2019 11:54am

Novartis headquarters

NICE hands Novartis a gene therapy win with Luxturna backing

Sep 4, 2019 10:59am